intermittent theta-burst stimulation (iTBS)
intermittent theta-burst stimulation (iTBS) is a medical device with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Exploring the Modulatory Role of Brain State on the Prefrontal Response to Excitatory Stimulation
Multicenter iTBS Neuromodulation for PTSD Treatment
Adjunctive iTBS for First-Episode Schizophrenia
Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study
Intermittent Theta-Burst Stimulation to Target Irritability in Adults With ASD
Clinical Trials (7)
Exploring the Modulatory Role of Brain State on the Prefrontal Response to Excitatory Stimulation
Multicenter iTBS Neuromodulation for PTSD Treatment
Adjunctive iTBS for First-Episode Schizophrenia
Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study
Intermittent Theta-Burst Stimulation to Target Irritability in Adults With ASD
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
Exploring the Cortical Hemodynamic Response of Excitatory Brain Stimulation: a Pilot Study
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7